Tilray has expanded its medicinal cannabis product offering in Australia and launched a new e-learning platform for healthcare providers on both sides of the Tasman.

A new Tilray-branded, GMP-certified 15g medicinal cannabis whole flower range is now available in Australia under the Special Access and Authorised Prescriber schemes.

Options include balanced whole flower (THC:10, CBD:10), mid-range THC (17), and high-THC (25) varieties.

Tilray head of international and chief strategy officer Denise Faltischek

The company has also launched an online medicinal cannabis education platform to help healthcare professionals in Australia and New Zealand understand the benefits of the plant.

Head of international and chief strategy officer Denise Faltischek said: “As medical cannabis demand increases worldwide, we remain committed to providing healthcare professionals and patients with safe and reliable access to the highest-quality products.” 

She added: “After listening to patient feedback and leveraging learnings from our operations in Germany, we are excited to be introducing new products in Australia that meet consumer needs.”

General manager Tilray Australia George Polimenakos said: “Cannabis education is paramount to everything we do and [we] are therefore excited to offer healthcare professionals the tools they need to learn about cannabis through our new e-learning platform.”

Tilray ran multiple medicinal cannabis workshops across Australia and New Zealand in 2021.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...